2014
FK506 protects against articular cartilage collagenous extra-cellular matrix degradation
Publication
Publication
Osteoarthritis and Cartilage , Volume 22 - Issue 4 p. 591- 600
Objective: Osteoarthritis (OA) is a non-rheumatologic joint disease characterized by progressive degeneration of the cartilage extra-cellular matrix (ECM), enhanced subchondral bone remodeling, activation of synovial macrophages and osteophyte growth. Inhibition of calcineurin (Cn) activity through tacrolimus (FK506) in invitro monolayer chondrocytes exerts positive effects on ECM marker expression. This study therefore investigated the effects of FK506 on anabolic and catabolic markers of osteoarthritic chondrocytes in 2D and 3D invitro cultures, and its therapeutic effects in an invivo rat model of OA. Methods: Effects of high and low doses of FK506 on anabolic (QPCR/histochemistry) and catabolic (QPCR) markers were evaluated invitro on isolated (2D) and ECM-embedded chondrocytes (explants, 3D pellets). Severe cartilage damage was induced unilaterally in rat knees using papain injections in combination with a moderate running protocol. Twenty rats were treated with FK506 orally and compared to twenty untreated controls. Subchondral cortical and trabecular bone changes (longitudinal microCT) and macrophage activation (SPECT/CT) were measured. Articular cartilage was analyzed exvivo using contrast enhanced microCT and histology. Results: FK506 treatment of osteoarthritic chondrocytes invitro induced anabolic (mainly collagens) and reduced catabolic ECM marker expression. In line with this, FK506 treatment clearly protected ECM integrity invivo by markedly decreasing subchondral sclerosis, less development of subchondral pores, depletion of synovial macrophage activation and lower osteophyte growth. Conclusion: FK506 protected cartilage matrix integrity invitro and invivo. Additionally, FK506 treatment invivo reduced OA-like responses in different articular joint tissues and thereby makes Cn an interesting target for therapeutic intervention of OA.
| Additional Metadata | |
|---|---|
| , , , , | |
| doi.org/10.1016/j.joca.2014.02.003, hdl.handle.net/1765/73485 | |
| Osteoarthritis and Cartilage | |
| Organisation | Department of Orthopaedics |
|
Siebelt, M., van der Windt, A., Groen, H., Sandker, M., Waarsing, J., Müller, C., … Weinans, H. (2014). FK506 protects against articular cartilage collagenous extra-cellular matrix degradation. Osteoarthritis and Cartilage, 22(4), 591–600. doi:10.1016/j.joca.2014.02.003 |
|
